OIMU
IDXX icon

Osmosis Investment Management UK’s Idexx Laboratories IDXX Stock Holding History

Osmosis Investment Management UK’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
2,441
-2,026
-45% -$1.14M 0.06% 232
2026
Q1 		$2.51M Sell
4,467
-1,700
-28% -$1.09M 0.07% 218
2025
Q4 		$4.17M Buy
+6,167
New +$4.2M 0.11% 183

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Osmosis Investment Management UK's IDXX Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Idexx Laboratories (IDXX) stake by 45% in Q2 2026, selling an estimated $1.14M and leaving 2,441 shares worth $1.29M. The position accounts for 0.06% of the portfolio, ranked #232.

Osmosis Investment Management UK first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.17M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Osmosis Investment Management UK held 2,441 shares of Idexx Laboratories worth $1.29M as of Q2 2026.
  • Osmosis Investment Management UK sold 2,026 Idexx Laboratories shares in Q2 2026, an estimated $1.14M.
  • Idexx Laboratories made up 0.06% of Osmosis Investment Management UK's portfolio in Q2 2026, its #232 holding.
  • Osmosis Investment Management UK first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Idexx Laboratories position peaked at $4.17M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.